NEW YORK--(BUSINESS WIRE)--Medidata Solutions (NASDAQ: MDSO), a global provider of hosted clinical development solutions, today announced a multi-year contract extension with Bristol-Myers Squibb Company (NYSE: BMY) for use of Medidata Grants Manager™, an investigator site benchmarking tool that helps sponsors ensure fair and consistent investigator payments, mitigate compliance risks and reduce trial start-up time. Under this new contract, Bristol-Myers Squibb will also be expanding its use of Grants Manager to include analysis and contracting modules.
